💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Galmed Pharmaceuticals Ltd. (GLMD)
« Back to company indexGLMD Chatter Timeline
Stock Ticker for GLMD
Most Active Tweeters for GLMD
| User | Tweets |
|---|---|
| @Tickeron | 5 |
| @FrnkTss | 1 |
Recent Tweets for GLMD
 |
@Tickeron $GLMD's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/1DGmhlGgIU December 1st 2021, 9:12pm |
 |
@FrnkTss https://t.co/2xJVWPWNz4 $GLMD 3rd bounce? https://t.co/6psZoLDRDY November 27th 2021, 6:11pm |
|
@Tickeron $GLMD enters a Downtrend as Momentum Indicator dropped below the 0 level on November 17, 2021. View odds for this a… https://t.co/kNp5J8Quz0 November 25th 2021, 7:11pm |
|
@Tickeron $GLMD in -9.4% Downtrend, falling for three consecutive days on November 18, 2021. View odds for this and other ind… https://t.co/Pzx8Br2r2f November 25th 2021, 4:11am |
|
@Tickeron $GLMD in -9.4% Downtrend, declining for three consecutive days on November 18, 2021. View odds for this and other i… https://t.co/YgDmEgTCpi November 24th 2021, 6:11am |
|
@Tickeron $GLMD in -9.4% Downtrend, falling for three consecutive days on November 18, 2021. View odds for this and other ind… https://t.co/XaVZIWshcR November 22nd 2021, 11:11pm |
 |
@techwhitepapers $GLMD few days ago the no1 professor in the world in the #nash space pretty much said that $GLMD Aramchol its bette… https://t.co/peK1bgUGYP November 12th 2021, 2:11pm |
 |
@mediasentiment $GLMD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 557 November 9th 2021, 8:11pm |
 |
@newsfilterio UPDATE 1-Bangladesh's Beximco to sell generic version of Merck COVID-19 pill $GLMD $MRK https://t.co/FpdilCyRh3 November 9th 2021, 8:11am |
 |
@Ethane28 $GLMD - $3 at close, but very interesting how Professor Vlad Ratziu said on the significance of data" So the prac..… https://t.co/b9cB26qxJT November 8th 2021, 9:11pm |
 |
@StckPro $GLMD NEW ARTICLE : Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q3 2021 Results - Earnings Call Transc… https://t.co/XjcPzh9dfy November 8th 2021, 8:11pm |
 |
@SeekingAlpha $GLMD - Galmed Pharmaceuticals Ltd. (GLMD) CEO Allen Baharaff on Q3 2021 Results - Earnings Call Transcript.… https://t.co/nxBgSTU5tT November 8th 2021, 8:11pm |
 |
@OptionHunt Ticker $GLMD Unusual Volume Detected: 102.54% over average November 8th 2021, 8:11pm |
|
@SeekingAlpha $GLMD - Galmed Pharmaceuticals Ltd. 2021 Q3 - Results - Earnings Call Presentation. https://t.co/We6rhEDmD0 #trading #economy #stockmarket November 8th 2021, 7:11pm |
|
@newsfilterio Galmed's NASH Candidate Shows Clinically Significant Effect On Fibrosis Improvement $GLMD https://t.co/zlhKlvKNHp November 8th 2021, 6:11pm |
 |
@MarcJacksonLA $GLMD Galmeds NASH Candidate Shows Clinically Significant Effect On Fibrosis Improvement $GLMD https://t.co/QPVQMS8h5t # via @benzinga November 8th 2021, 5:11pm |
 |
@SmallCapsDaily $GLMD Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of ARMOR Study and Reports… https://t.co/gHuti7Frk3 November 8th 2021, 3:11pm |
 |
@MRInvestorTr I’m buying more $GLMD. Clinical results is good than my expectation . Buyout , Partnership why not? November 8th 2021, 3:11pm |
 |
@AlertTrade UP WITH EARNINGS: $GLMD Galmed Pharmaceuticals Ltd. Ordinary Shares ? TradeIdeas via ? https://t.co/VS8RO1bzXJ November 8th 2021, 2:11pm |
 |
@juliaskripkaser $GLMD out with open-label histology part of Phase 3, absolute yawn. Now onto the randomized part, histology data in… https://t.co/xm5xfJtsct November 8th 2021, 1:11pm |
 |
@investor_feed $GLMD 6-K Galmed Pharmaceuticals (8 Nov, 8:25am) ? Galmed Pharmaceuticals Provides Additional Positive Data fr… https://t.co/TF8SeExbaN November 8th 2021, 1:11pm |
 |
@optstrader1 $GLMD is it for real? November 8th 2021, 12:11pm |
 |
@OryoJohn $GLMD: Galmed Announces New Positive Data from Ongoing ARMOR Study Open Label Part Showing Clinically Significant E… https://t.co/jDJfX5SYeO November 8th 2021, 12:11pm |
 |
@OpenOutcrier $GLMD (+12.1% pre) Galmed Announces New Positive Data from Ongoing ARMOR Study Open Label Part Showing Clinically S… https://t.co/U0Ct4Mmx0Y November 8th 2021, 12:11pm |
 |
@GapUp4 $GLMD Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of ARMOR Study and Reports… https://t.co/ITPKATNqlu November 8th 2021, 12:11pm |
|
@mediasentiment $GLMD new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 426 November 8th 2021, 12:11pm |
|
@StckPro $GLMD NEW ARTICLE : Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of ARMOR Stud… https://t.co/ccgdMwOkEb November 8th 2021, 12:11pm |
 |
@MarketCurrents $GLMD - Galmed EPS beats by $0.67 https://t.co/kiceJzSLBF November 8th 2021, 12:11pm |
 |
@FlashAlert_me $GLMD [15s. delayed, acc.~90%, always check] Earnings Release November 08, 07:30:00: Q3: GAAP EPS of $0.31 https://t.co/LfleYC0U7f November 8th 2021, 12:11pm |
|
@FlashAlert_me $GLMD [15s. delayed]: Issued Press Release on November 08, 07:30:00: Galmed Pharmaceuticals Provides Additional Pos… https://t.co/YOOMiQM4pg November 8th 2021, 12:11pm |
 |
@StockNewsBot2 $GLMD Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of ARMOR Study and Reports… https://t.co/8JKKIf4uKw November 8th 2021, 12:11pm |
 |
@stock_titan $GLMD Galmed Pharmaceuticals Provides Additional Positive Data from the Open Label Part of ARMOR Study and Reports… https://t.co/JmK2ZgDIcA November 8th 2021, 12:11pm |
 |
@63_hyacinth Galmed announces results from ARMOR Phase 3 study $GLMD November 8th 2021, 12:11pm |
|
@Ethane28 $GLMD “We believe Aramchol at a higher dose stands out as a leading compound for the treatment of liver fibrosis." https://t.co/aFrvmHjyyu November 8th 2021, 12:11pm |
 |
@LowFloatMagic $GLMD 3.12 up 11% just hit PM high on above avg volume, announced positive results in part of ARMOR study??? https://t.co/bJxzsuBpGQ November 8th 2021, 12:11pm |
 |
@Kelcey88059806 $GLMD on watch, 21M free float, earnings today (very soon?) And new + data CLINICALLY SIGNIFICANT for fibrosis impr… https://t.co/4NdrYOB0jb November 8th 2021, 12:11pm |
 |
@James__BondOO7 RT @stock_titan: $GLMD Galmed Announces New Positive Data from Ongoing ARMOR Study Open Label Part Showing Clinically Significant Effect on… November 8th 2021, 12:11pm |
|
@StockNewsBot2 $GLMD Galmed Announces New Positive Data from Ongoing ARMOR Study Open Label Part Showing Clinically Significant Ef… https://t.co/zHss1hfZJj November 8th 2021, 12:11pm |
|
@stock_titan $GLMD Galmed Announces New Positive Data from Ongoing ARMOR Study Open Label Part Showing Clinically Significant Ef… https://t.co/YnJgmhO2aa November 8th 2021, 12:11pm |
 |
@SwingTradeIdeas $GLMD is up 13.31% on 87,958 volume. Now trading at $3.15. #GLMD #premarketscan November 8th 2021, 10:11am |
 |
@ChartMill $GLMD has a bad technical rating, but it does show a decent setup pattern. https://t.co/3KB2c8p0YI https://t.co/M5ZItfvtlp November 8th 2021, 10:11am |
|
@Tickeron Galmed Pharmaceuticals Ltd to report earnings on November 08, 2021. Earnings per share (EPS) estimate: $-0.35 $GLMD… https://t.co/7Da40lzxTN November 8th 2021, 6:11am |
 |
@mana_podcast @Pharmdca bhai check $GLMD Nash play with Phase 3, just around 60 MC, no one knows about it...entered recently, please your view also ? November 2nd 2021, 10:11pm |
 |
@SwingTradeBot Reversed from Down today: $GLMD ... https://t.co/uuYYhupj1A November 2nd 2021, 7:11pm |
 |
@slattii $GLMD anyone paying attention ? https://t.co/xkbhgnKi0i https://t.co/Q0XSWt1ZiW November 2nd 2021, 1:11pm |
 |
@Uncletrade1 $GLMD Waiting for Buy signal on GLMD https://t.co/rViejevq7y November 2nd 2021, 1:11pm |
|
@MarcJacksonLA $GLMD Galmed Announces Positive Results from First 16 Patients in Open-Label Part of ARMOR Study https://t.co/eLuWlbhjQR via @salamancaPress November 1st 2021, 5:11pm |
|
@MarcJacksonLA $GLMD Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial $GLMD https://t.co/s6lzS4E9te # via @benzinga November 1st 2021, 5:11pm |
|
@newsfilterio Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial $GLMD https://t.co/DWJKAwpTb7 November 1st 2021, 4:11pm |
|
@SmallCapsDaily $GLMD Galmed Announces Positive Results from First 16 Patients in Open-Label Part of ARMOR Study PR Newswire… https://t.co/cPBUE5P8pQ November 1st 2021, 3:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?